Myeloid-derived suppressor cells in ovarian cancer: friend or foe?

Monika Walankiewicz1,2, Ewelina Grywalska1, Grzegorz Polak2

  • 1Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Poland.

Insights

Myeloid-derived suppressor cells (MDSCs) play a critical role in the immunosuppressive microenvironment of epithelial ovarian cancer (EOC). Understanding MDSCs offers new diagnostic and therapeutic strategies for this challenging gynecological malignancy.

Area of Science:

  • Gynecological Oncology
  • Immunology
  • Cancer Biology

Background:

  • Gynaecological cancers, particularly epithelial ovarian cancer (EOC), present significant treatment challenges despite advances in targeted therapies.
  • High incidence and mortality rates, coupled with late-stage diagnoses, underscore the urgent need for novel therapeutic approaches.
  • The tumor microenvironment, especially its immune suppressive aspects, is crucial for understanding cancer progression and developing new treatments.

Purpose of the Study:

  • To review current knowledge on the role of myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer (EOC).
  • To explore the potential of targeting MDSCs for improved diagnosis and treatment of EOC.
  • To highlight the significance of immune interactions in overcoming treatment resistance in gynecological cancers.

Main Methods:

  • Comprehensive literature review of studies investigating myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer (EOC).
  • Analysis of mechanisms by which MDSCs contribute to the immunosuppressive tumor microenvironment in EOC.
  • Synthesis of evidence regarding the diagnostic and therapeutic implications of MDSCs in EOC.

Main Results:

  • Accumulation of myeloid-derived suppressor cells (MDSCs) is a critical component of the immunosuppressive microenvironment in epithelial ovarian cancer (EOC).
  • MDSCs contribute to immune evasion and treatment resistance in EOC by suppressing anti-tumor immune responses.
  • The presence and activity of MDSCs may serve as potential biomarkers for diagnosis and prognostication in EOC.

Conclusions:

  • Myeloid-derived suppressor cells (MDSCs) are significantly implicated in the pathogenesis and progression of epithelial ovarian cancer (EOC).
  • Targeting MDSCs represents a promising strategy for developing novel immunotherapies and improving diagnostic tools for EOC.
  • Further research into the complex interplay between MDSCs and the EOC tumor microenvironment is essential for advancing gynecological cancer treatment.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K